6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review
Key Takeaways
- A hospital may not reprocess single-use devices in-house unless it registers with the FDA as a manufacturer and meets all manufacturer requirements including premarket submission and quality system regulation.
- The manufacturer's instructions for use are the legal and regulatory standard for reprocessing, and conflicts between device, detergent, and sterilizer instructions must be resolved with the manufacturers rather than at the bedside.
- Reprocessability must be evaluated before purchase, because a device requiring a cycle, brush, or drying time the facility cannot provide becomes an unusable or unsafe purchase.
- Loaner and consignment instruments must arrive with sufficient lead time and complete instructions, and must be decontaminated and inspected on arrival even when labeled sterile.
- Immediate use steam sterilization is reserved for genuine emergencies, must never be used for implants except in documented emergencies, and must never compensate for inadequate instrument inventory.
6.4 Single-Use Devices, Outsourced Reprocessing, & IFU Review
Quick Answer: A device labeled single-use may not be reprocessed by the hospital unless the hospital registers with FDA as a manufacturer. Commercially reprocessed single-use devices are legal because third-party reprocessors are held to full manufacturer requirements. The manufacturer's instructions for use (IFU) are the standard — and must be reviewed before purchase, not after a device arrives.
The blueprint asks candidates to assist in reviewing product use and reprocessing requirements, naming single-use, on-site, and outsourced reprocessing. These are procurement and contracting decisions that determine whether frontline reprocessing can succeed at all.
Single-Use Devices
A single-use device (SUD) is labeled by its manufacturer for use on one patient during one procedure. Common examples include biopsy forceps, sphincterotomes, many electrophysiology catheters, laparoscopic shears, and pulse oximeter probes.
The regulatory position
| Actor | May reprocess an SUD? | Requirements |
|---|---|---|
| Original manufacturer | Yes, if validated and labeled for it | Standard manufacturer obligations |
| Third-party commercial reprocessor | Yes | Registered with FDA as a manufacturer: premarket submission (510(k) where required), Quality System Regulation, validated cleaning and sterilization, adverse-event reporting, labeling as "reprocessed" |
| Hospital, in-house | Only if it registers as a manufacturer and meets every requirement above | In practice, effectively no |
Since FDA's 2000 guidance, reprocessing SUDs has been regulated identically to original manufacture. Commercially reprocessed SUDs from a registered reprocessor are a legitimate, FDA-cleared cost and sustainability strategy; informal in-house reuse is not. The distinction that gets facilities into trouble is quietly re-sterilizing a single-use item because it "looks fine" and inventory is short.
Exam Tip: The correct answer to "the facility wants to reuse single-use devices to reduce cost" is to contract with an FDA-registered third-party reprocessor, not to reprocess in-house and not to reuse without processing.
Instructions for Use: The Governing Document
The IFU is not advisory. It is the validated process, and departing from it invalidates the manufacturer's claims, voids warranties, and creates regulatory and liability exposure.
What the IFU must specify
- Point-of-use treatment and maximum delay before cleaning
- Disassembly steps
- Detergent type, concentration, temperature, and soak time
- Brush sizes and channel cleaning specifics
- Rinse water quality (utility, purified, or sterile)
- Compatible disinfectants and disinfectants that must not be used
- Sterilization modality, cycle type, temperature, exposure time, and dry time
- Number of validated reprocessing cycles, where limited
- Inspection and functional testing criteria
The IFU conflict problem
A single tray can involve three or four IFUs — device, container, detergent, sterilizer — that do not agree. A device may require a 4-minute dynamic-air-removal cycle at 132°C with a 30-minute dry time, while the rigid container is validated for a different dry time and the facility's sterilizer offers neither cycle.
These conflicts must be resolved in writing with the manufacturers before the device is used, and the resolution must be documented. They are never resolved by a technician choosing the closest available cycle.
Reviewing before purchase
Infection prevention should be a standing member of the value analysis / product standardization committee, and should ask before any purchase:
- Can we physically perform this reprocessing — the brushes, the cycle, the drying, the space?
- Do we have the required sterilizer cycle and validated container?
- What is the turnaround time, and does our inventory support it without pressure to shortcut?
- Are test strips, leak testers, borescopes or other verification tools required and available?
- Is training required, and who provides it?
- Is the IFU complete and in English, and is a current copy accessible in the reprocessing area?
- Does the device have known reprocessing design problems (complex lumens, elevator mechanisms, hinged joints)?
A device that cannot be reprocessed correctly at this facility should not be purchased. That decision is far cheaper before the contract than after an outbreak.
Outsourced Reprocessing
When reprocessing is contracted out, the facility retains accountability for the outcome. The contract and oversight must address:
| Element | Requirement |
|---|---|
| Vendor qualification | Documented validated processes, personnel certification, quality monitoring; on-site audit at defined intervals |
| Transport of contaminated devices | Leak-proof, biohazard-labeled containment; defined time limits so bioburden does not dry |
| Transport of processed devices | Protection of package integrity and sterility during transit and storage |
| Process verification | Sterilization records, biological and chemical indicator results supplied with each load |
| Failure notification | Contractual duty to notify the facility immediately of any process failure affecting delivered devices |
| Recall support | Ability to identify which facility devices were in an affected load |
Loaner and consignment instruments
Loaner trays are a recurring failure point: they arrive late, are unfamiliar, come with missing or generic IFUs, and are sometimes labeled "sterile" by a vendor whose process the facility has never verified.
Policy should require:
- Arrival lead time sufficient for full decontamination and sterilization — commonly at least two business days before the case
- Decontamination and sterilization on arrival regardless of labeling, because the facility cannot verify an outside process
- Complete, device-specific IFUs delivered with the tray
- Inventory verification and inspection against a count sheet on receipt and return
- No direct-to-OR delivery bypassing sterile processing
Immediate Use Steam Sterilization (IUSS)
Formerly called "flash sterilization," IUSS processes an unwrapped or containerized item for immediate use with no storage.
| Acceptable | Not acceptable |
|---|---|
| A single instrument dropped during a procedure with no replacement available | Routine processing because inventory is inadequate |
| A genuinely emergent, unanticipated need | Convenience or to shorten turnover time |
| Implantable devices — except in a documented emergency, and then only with a rapid-readout biological indicator and full documentation |
Every IUSS cycle must be documented with the item, the reason, the cycle parameters, the patient, and the monitoring results. A rising IUSS rate is an inventory problem, a scheduling problem, or a workflow problem — and it is one of the most informative metrics an IP can trend in the perioperative environment.
A surgery department proposes reprocessing single-use laparoscopic shears in the facility's sterile processing department to reduce costs. What is the correct infection prevention response?
A new instrument set's IFU specifies a sterilization cycle the facility's sterilizers cannot run, and the rigid container's IFU specifies a different dry time. How should this be resolved?
A vendor delivers a loaner orthopedic tray to the operating room two hours before the case, labeled sterile by the vendor. What should facility policy require?
An infection preventionist notices the operating room's immediate use steam sterilization rate has tripled over six months. What does this most likely indicate?